Levitra

Another question is whether the market is large enough.

Federal figures show that about 750,000 African-Americans are suffering from the type of heart failure for which BiDil is intended.

Whether that patient population is large enough to sustain profitability is one question that must be answered.NitroMed and the National Association for the Advancement of Colored People (NAACP) recently launched an initiative to inform Medicare beneficiaries about the existence of BiDil for those with heart problems.All that being said, NitroMed is doing its best to sell its new medication.In recent weeks, it promoted Dr.

Michael Sabolinski to the post of chief medical officer.

He replaces cofounder Manuel Worcel, who in the mid-1990s had been chief executive officer.Sabolinski joined NitroMed in 2002 as senior vice president for clinical development and regulatory affairs.

He joined NitroMed from Organogenesis Inc., where had been chief executive officer among other posts.And it has added Gerald Bruce as vice president of sales and Lisa Kelly as head of human resources.Bruce was formerly with Bristol-Myers Squibb Co., where he was the vice president of private-sector strategy and accounts.

He had held various leadership roles at Johnson & Johnson for 15 years.Kelly was most recently the senior vice president of health care and service operations at CIGNA where she led the human resources...

Read more...